A Randomized, Double-blind Study of the Effect of the DPP-IV Inhibitor on HbA1c and Safety in Patients With Type 2 Diabetes
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2016
At a glance
- Drugs RO 0730699 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Actual patient number added as 291 as reported by ClinicalTrials.gov.
- 29 Aug 2006 Status change
- 02 Jun 2006 New trial record.